Skip to Main Content

Paper Details

Cardiac and vascular serious adverse events following tixagevimab-cilgavimab.
Lancet Respir Med
8
2023
Author NameAffiliation
Srinivas MurthyUniversity of British Columbia
  • 1 - 1

Datasets

Release 1.2